Dementia with Lewy Bodies

The objective was to summarize recent findings about the clinical features, diagnosis and investigation of dementia with Lewy (DLB) bodies, together with its neuropathology, neurochemistry and genetics. Dementia with Lewy bodies (DLB) is a primary, neurodegenerative dementia sharing clinical and pathological characteristics with both Parkinson's disease (PD) and Alzheimer's disease (AD). Antiubiquitin immunocytochemical staining, developed in the early 1990s, allowed the frequency and distribution of cortical LBs to be defined. More recently, alpha-synuclein antibodies have revealed extensive neuritic pathology in DLB demonstrating a neurobiological link with other "synucleinopathies" including PD and multiple system atrophy (MSA). The most significant correlates of cognitive failure in DLB appear to be with cortical LB and Lewy neurites (LNs) rather than Alzheimer type pathology. Clinical diagnostic criteria for DLB, published in 1996, have been subjected to several validation studies against autopsy findings. These conclude that although diagnostic specificity is high (range 79- 100%, mean 92%), sensitivity is lower (range 0- 83 %, mean, 49%). Improved methods of case detection are therefore required. Fluctuating impairments in attention, visual recognition and construction are more indicative of DLB than AD. Relative preservation of medial temporal lobe volume on structural MRI and the use of SPECT tracers for regional blood flow and the dopamine transporter are the most reliable current biomarkers for DLB. There are no genetic or CSF tests recommended for the diagnosis of DLB at present. Between 15 and 20% of all elderly demented cases reaching autopsy have DLB, making it the most common cause of degenerative dementia after AD. Exquisite, not infrequently fatal, sensitivity to neuroleptic drugs and encouraging reports of the effects of cholinesterase inhibitors on cognitive, psychiatric and neurological features, mean that an accurate diagnosis of DLB is more than merely of academic interest. Dementia developing late in the course of PD shares many of the same clinical and pathological characteristics.

[1]  Murat Emre,et al.  Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study , 2000, The Lancet.

[2]  Glenda M. Halliday,et al.  Cortical Lewy body pathology in the diagnosis of dementia , 2001, Acta Neuropathologica.

[3]  I. Alafuzoff,et al.  α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia , 2005, Annals of neurology.

[4]  I. McKeith,et al.  High prevalence of neurovascular instability in neurodegenerative dementias , 1998, Neurology.

[5]  I. McKeith,et al.  The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease , 2001, International journal of geriatric psychiatry.

[6]  Ian G. McKeith,et al.  Comparison of Extrapyramidal Signs in Dementia With Lewy Bodies and Parkinson's Disease , 2001 .

[7]  R. Hamilton,et al.  Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry , 2000, Brain pathology.

[8]  I. McKeith,et al.  A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia , 2001, International journal of geriatric psychiatry.

[9]  A. Swann,et al.  One Year Follow-Up of Parkinsonism in Dementia with Lewy Bodies , 2000, Dementia and Geriatric Cognitive Disorders.

[10]  J. Grace,et al.  Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease , 1998, The Lancet.

[11]  L. Thal,et al.  The Lewy body variant of Alzheimer's disease , 1990, Neurology.

[12]  E. Perry,et al.  Neuroleptic sensitivity in patients with senile dementia of Lewy body type. , 1992, BMJ.

[13]  J D Fenwick,et al.  Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD , 2001, Neurology.

[14]  I G McKeith,et al.  The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. , 2000, The British journal of psychiatry : the journal of mental science.

[15]  Alan Thomas,et al.  Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross‐sectional comparative study , 2003, Movement disorders : official journal of the Movement Disorder Society.

[16]  Robert H. Perry,et al.  Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly , 1990, Journal of the Neurological Sciences.

[17]  W. Gibb,et al.  Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). , 1987, Brain : a journal of neurology.

[18]  D. Salmon,et al.  Rapidly progressive dementia in a patient with the Lewy body variant of Alzheimer's disease , 1991, Neurology.

[19]  R. Schiffer,et al.  Psychiatric features in diffuse Lewy body disease , 1996, Neurology.

[20]  B. Boeve,et al.  REM Sleep Behavior Disorder in Parkinson’s Disease and Dementia with Lewy Bodies , 2004, Journal of geriatric psychiatry and neurology.

[21]  C. Katona,et al.  In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies , 1999, The Lancet.

[22]  I G McKeith,et al.  The role of levodopa in the management of dementia with Lewy bodies , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[23]  M N Rossor,et al.  Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia , 2001, Neurology.

[24]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[25]  Janel O. Johnson,et al.  SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies , 2004, Neurology.

[26]  D W Dickson,et al.  DLB fluctuations , 2004, Neurology.

[27]  R. N. Mohan,et al.  Idiopathic clouding of consciousness—do the patients have cortical lewy body disease? , 1993 .

[28]  P. Lantos,et al.  Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies , 1999, British Journal of Psychiatry.

[29]  K Kosaka,et al.  Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? , 1984, Clinical neuropathology.

[30]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[31]  V Hachinski,et al.  Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease , 1996, Neurology.

[32]  G. Livingston,et al.  Islington study of dementia subtypes in the community. , 2002, The British journal of psychiatry : the journal of mental science.

[33]  D. Birkett,et al.  Lewy bodies in psychiatric patients , 1992 .

[34]  J. Trojanowski,et al.  Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases , 2002, Annals of neurology.

[35]  R. Godwin-Austen,et al.  Dementia associated with cortical Lewy bodies : proposed clinical diagnostic criteria , 1991 .

[36]  S. Shergill,et al.  What is the clinical prevalence of lewy body dementia? , 1994 .

[37]  I. McKeith,et al.  Dementia with Lewy bodies , 1999, Neurology.

[38]  J Bradshaw,et al.  Fluctuating cognition in dementia with Lewy bodies and Alzheimer’s disease is qualitatively distinct , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[39]  C. Katona,et al.  Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies , 2000, International journal of geriatric psychiatry.

[40]  I. McKeith,et al.  Dementia with Lewy bodies and other difficult diagnoses , 2004, International Psychogeriatrics.

[41]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[42]  C G Ballard,et al.  Fluctuations in attention , 2002, Neurology.

[43]  R. Sulkava,et al.  Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older , 2003, Journal of neurology, neurosurgery, and psychiatry.